NGVT Stock Rallies 31% in a Year: What's Driving the Upside?

Zacks
Apri Zacks
NGVT Stock Rallies 31% in a Year: What's Driving the Upside?

Ingevity Corporation’s NGVT shares have rallied 30.6% in the past year. The company has also outperformed the Zacks Chemical - Specialty industry’s 0.2% growth over the same time frame. Ingevity’s portfolio optimization actions, investments in capacity and debt reduction supported by higher cash flows have boosted investor confidence in its long-term growth prospects.

Zacks Investment Research
Image Source: Zacks Investment Research

Let’s take a look at the factors that are driving NGVT stock. 

Portfolio Transformation and New Growth Opportunities

Ingevity has been benefiting from its portfolio transformation strategy, supported by strategic divestitures, acquisitions and successful repositioning efforts. The divestiture of the Industrial Specialties business and Road Markings product line, along with the ongoing sale process for the APT business, is optimizing the company’s portfolio and increasing focus on higher-return opportunities.

The elimination of $10 million of stranded costs and acquisitions of Georgia-Pacific’s pine chemicals business, Capa caprolactone business and Ozark Materials are further strengthening the portfolio through manufacturing optimization, lower logistics costs, new technology platforms and more market opportunities. Meanwhile, PFAS filtration contract, European biofuels applications for TOFA and capacity expansions in soy-based fatty acids, caprolactone and polyols are creating opportunities for long-term growth.

Cash Flow and Capital Allocation Support Returns

Improving cash generation and disciplined capital allocation have also supported Ingevity’s performance. In the second quarter, free cash flow excluding the litigation settlement payment reached approximately $89 million, while debt reduction lowered leverage to 2.5X. The company’s focus on further reducing leverage to 2X-2.5X, alongside the plan to repurchase $300 million of shares through 2027, underscores its commitment to strengthening the balance sheet while returning capital to shareholders.

Ingevity Corporation Price and Consensus

Ingevity Corporation Price and Consensus

Ingevity Corporation price-consensus-chart | Ingevity Corporation Quote

NGVT’s Zacks Rank & Other Key Picks

NGVT currently carries a Zacks Rank #2 (Buy).

Other top-ranked stocks in the Basic Materials space are Reliance, Inc. RS, Avient Corporation AVNT and Kronos Worldwide, Inc. KRO.

AVNT sports a Zacks Rank #1 (Strong Buy) at the moment, while RS and KRO carry a Zacks Rank #2 each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. RS’shares have gained 36.7% over the past year.

The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’sshares have gained 27.3% over the past year.

The Zacks Consensus Estimate for KRO’s 2026 earnings is pegged at 35 cents per share, indicating a rise of 136.5% year over year. KRO’s earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the rest, with an average surprise of 34%.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ingevity Corporation (NGVT): Free Stock Analysis Report
 
Reliance, Inc. (RS): Free Stock Analysis Report
 
Kronos Worldwide Inc (KRO): Free Stock Analysis Report
 
Avient Corporation (AVNT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research